FORMULIERUNGEN AUS BENDAMUSTIN

Patent europeic · EP3158991 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3158991
Numer da la dumonda
EP16020363
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
28-01-2011
Publitgà
26-04-2017
Concedì
17-03-2021
Stritgà
24-08-2022
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/08 (2006.01)
A61K 31/4184 (2006.01)
A61K 47/10 (2017.01)
A61K 47/20 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 299100 P 28.01.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-08-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.08.2022

  2. 26-01-2022

    Midada

    Published in Swissreg on 26.01.2022

  3. 17-03-2021

    Concedì

    Published in Swissreg on 17.03.2021

Partidas

Possessur

Eagle Pharmaceuticals, Inc.

50 Tice Boulevard, Woodcliff Lake, NJ 07677, US

Inventur

Palepu, Nagesh R.

Southampton, Pennsylvania 18966, US

Buxton, Philip Christopher

Great Dunmow, Essex CM6 2PB, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.